1. Home
  2. BMY
  3. BMY News

Latest Bristol-Myers Squibb Company (BMY) News on July 27, 2024

Bristol Myers Retakes Its 200-Day Line On Quarterly Beat, Surprise Immunology Win
BMY

Investor's Business Daily

4 hours ago

Bristol Myers Retakes Its 200-Day Line On Quarterly Beat, Surprise Immunology Win

BMY

MT Newswires

6 hours ago

Cantor Fitzgerald Raises Price Target on Bristol-Myers Squibb to $50 From $45

These Stocks Are Moving the Most Today: DexCom, 3M, Nvidia, Bristol Myers, Coursera, Biogen, Charter, Deckers, and More
BMY

Barrons.com

6 hours ago

These Stocks Are Moving the Most Today: DexCom, 3M, Nvidia, Bristol Myers, Coursera, Biogen, Charter, Deckers, and More

Why Bristol Myers Squibb Jumped Nearly 10% on Friday
BMY

Motley Fool

7 hours ago

Why Bristol Myers Squibb Jumped Nearly 10% on Friday

Bristol Myers Squibb (BMY) Q2 2024 Earnings Call Transcript
BMY

Motley Fool

8 hours ago

Bristol Myers Squibb (BMY) Q2 2024 Earnings Call Transcript

BMY

Associated Press Finance

8 hours ago

Newell Brands, 3M rise; Saia, DexCom fall, Friday, 7/26/2024

BMY

MT Newswires

9 hours ago

Top Midday Stories: Fed's Preferred Inflation Reading Up in June; 3M's Adjusted Earnings Gain; DexCom Cuts 2024 Revenue Guidance; Bristol-Myers Squibb's Higher Results; WesBanco, Premier Financial to Merge

Stocks to Watch Friday: DexCom, 3M, Coinbase, Charter
BMY

The Wall Street Journal

9 hours ago

Stocks to Watch Friday: DexCom, 3M, Coinbase, Charter

BMY

MT Newswires

12 hours ago

Sector Update: Health Care

Stock Futures Rise as Chip Shares Rally
BMY

The Wall Street Journal

12 hours ago

Stock Futures Rise as Chip Shares Rally

Bristol Myers Squibb (BMY) Q2 Earnings and Revenues Surpass Estimates
BMY

Zacks

13 hours ago

Bristol Myers Squibb (BMY) Q2 Earnings and Revenues Surpass Estimates

Bristol Myers Squibb Witnesses Strong Demand For 'Newer Drugs' As Q2 Earnings Beat Expectations, Raises 2024 Profit Forecast
BMY

Benzinga

13 hours ago

Bristol Myers Squibb Witnesses Strong Demand For 'Newer Drugs' As Q2 Earnings Beat Expectations, Raises 2024 Profit Forecast

Bristol Myers Stock Rises. A Sales Jump for Eliquis Boosts Earnings.
BMY

Barrons.com

13 hours ago

Bristol Myers Stock Rises. A Sales Jump for Eliquis Boosts Earnings.

BMY

MT Newswires

13 hours ago

Bristol-Myers' Q2 Non-GAAP Earnings, Revenue Rise; Lifts 2024 Non-GAAP EPS Guidance

Bristol Myers Squibb Earnings Easily Beat On Cost Cuts; Stock Jumps
BMY

Investor's Business Daily

14 hours ago

Bristol Myers Squibb Earnings Easily Beat On Cost Cuts; Stock Jumps

June PCE, Bristol Myers Squibb earnings: What to watch Friday
BMY

Yahoo Finance Video

a day ago

June PCE, Bristol Myers Squibb earnings: What to watch Friday

2 High-Yield Dividend Stocks Billionaires Are Buying. Are They Right for You?
BMY

Motley Fool

2 days ago

2 High-Yield Dividend Stocks Billionaires Are Buying. Are They Right for You?

What Lies in Store for Healthcare ETFs in Q2 Earnings?
BMY

Zacks

2 days ago

What Lies in Store for Healthcare ETFs in Q2 Earnings?

The Zacks Analyst Blog Highlights Boston Scientific, Thermo Fisher Scientific, Align Technology and Edwards Lifesciences
BMY

Zacks

2 days ago

The Zacks Analyst Blog Highlights Boston Scientific, Thermo Fisher Scientific, Align Technology and Edwards Lifesciences

Should You Buy, Sell or Hold Bristol Myers (BMY) Before Q2 Earnings?
BMY

Zacks

3 days ago

Should You Buy, Sell or Hold Bristol Myers (BMY) Before Q2 Earnings?

Will These 5 Medical Stocks Surpass Q2 Earnings Forecasts?
BMY

Zacks

3 days ago

Will These 5 Medical Stocks Surpass Q2 Earnings Forecasts?

BMY

MT Newswires

4 days ago

Deutsche Bank Adjusts Bristol-Myers Squibb Price Target to $45 From $53, Maintains Hold Rating

BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: What to Know Ahead of Q2 Release
BMY

Zacks

4 days ago

BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: What to Know Ahead of Q2 Release

EMA Begins Review of Bristol Myers' (BMY) Opdivo Plus Yervoy for HCC
BMY

Zacks

4 days ago

EMA Begins Review of Bristol Myers' (BMY) Opdivo Plus Yervoy for HCC

BMY

MT Newswires

4 days ago

Jefferies Adjusts Price Target on Bristol-Myers Squibb to $49 From $54

Investors in Bristol-Myers Squibb (NYSE:BMY) from three years ago are still down 30%, even after 5.4% gain this past week
BMY

Simply Wall St.

5 days ago

Investors in Bristol-Myers Squibb (NYSE:BMY) from three years ago are still down 30%, even after 5.4% gain this past week

BMY

MT Newswires

7 days ago

Bristol-Myers Gets EMA Validation For Opdivo Combination Application to Treat Liver cancer

Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out for
BMY

Zacks

7 days ago

Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out for

Bristol Myers Squibb Receives European Medicines Agency Validation of Application for Opdivo (nivolumab) plus Yervoy (ipilimumab) for First-Line Treatment of Unresectable or Advanced Hepatocellular Carcinoma
BMY

Business Wire

8 days ago

Bristol Myers Squibb Receives European Medicines Agency Validation of Application for Opdivo (nivolumab) plus Yervoy (ipilimumab) for First-Line Treatment of Unresectable or Advanced Hepatocellular Carcinoma

Bristol Myers Squibb (BMY) Declines More Than Market: Some Information for Investors
BMY

Zacks

8 days ago

Bristol Myers Squibb (BMY) Declines More Than Market: Some Information for Investors

BMY

MT Newswires

8 days ago

Bristol Myers Squibb Validates Net-Zero Goals through Science Based Targets Initiative

Collect $2,000 in Dividends Per Year by Investing $35,000 in These 3 Stocks
BMY

Motley Fool

9 days ago

Collect $2,000 in Dividends Per Year by Investing $35,000 in These 3 Stocks

BMY

MT Newswires

9 days ago

TD Cowen Adjusts Price Target on Bristol-Myers Squibb to $45 From $67

Bristol-Myers Squibb Insiders Sold US$1.1m Of Shares Suggesting Hesitancy
BMY

Simply Wall St.

10 days ago

Bristol-Myers Squibb Insiders Sold US$1.1m Of Shares Suggesting Hesitancy

BMY

MT Newswires

11 days ago

Goldman Sachs Trims Price Target on Bristol-Myers Squibb to $55 From $56, Buy Rating Maintained

Legend Biotech (LEGN) Up 12% on Reports of Takeover Bid
BMY

Zacks

11 days ago

Legend Biotech (LEGN) Up 12% on Reports of Takeover Bid

Got $500? 2 No-Brainer Growth Stocks to Buy and Hold Forever
BMY

Motley Fool

12 days ago

Got $500? 2 No-Brainer Growth Stocks to Buy and Hold Forever

3 High-Yielding Dividend Stocks Near Their 52-Week Lows
BMY

Motley Fool

14 days ago

3 High-Yielding Dividend Stocks Near Their 52-Week Lows

2 Pharma Stocks to Buy Hand Over Fist This Month
BMY

Motley Fool

14 days ago

2 Pharma Stocks to Buy Hand Over Fist This Month

Bristol Myers (BMY) Loses 20.5% YTD: Should You Retain or Fold?
BMY

Zacks

14 days ago

Bristol Myers (BMY) Loses 20.5% YTD: Should You Retain or Fold?

BMY

MT Newswires

14 days ago

UBS Cuts Bristol-Myers Squibb Price Target to $43 From $47, Maintains Neutral Rating

Bristol Myers Squibb (BMY) Suffers a Larger Drop Than the General Market: Key Insights
BMY

Zacks

15 days ago

Bristol Myers Squibb (BMY) Suffers a Larger Drop Than the General Market: Key Insights

Nurix Therapeutics, Inc. (NRIX) Reports Q2 Loss, Lags Revenue Estimates
BMY

Zacks

15 days ago

Nurix Therapeutics, Inc. (NRIX) Reports Q2 Loss, Lags Revenue Estimates

Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
BMY

Zacks

15 days ago

Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It

BMY

MT Newswires

16 days ago

Redburn Atlantic Adjusts Price Target on Bristol-Myers Squibb to $50 From $54, Maintains Neutral Rating

Bristol-Myers Squibb Company (NYSE:BMY) is a favorite amongst institutional investors who own 78%
BMY

Simply Wall St.

16 days ago

Bristol-Myers Squibb Company (NYSE:BMY) is a favorite amongst institutional investors who own 78%

BMY

MT Newswires

16 days ago

Barclays Adjusts Price Target on Bristol-Myers Squibb to $41 From $43

Want $1,000 in Reliable Dividend Income? Invest $11,800 in these 3 Ultra-High-Yield Dividend Stocks.
BMY

Motley Fool

17 days ago

Want $1,000 in Reliable Dividend Income? Invest $11,800 in these 3 Ultra-High-Yield Dividend Stocks.

3 High-Yield S&P 500 Dividend Stocks That You Can Buy With $100 Right Now
BMY

Motley Fool

18 days ago

3 High-Yield S&P 500 Dividend Stocks That You Can Buy With $100 Right Now

Bristol Myers Squibb to Participate in UBS Virtual Targeted Protein Degradation Day
BMY

Business Wire

19 days ago

Bristol Myers Squibb to Participate in UBS Virtual Targeted Protein Degradation Day

3 Reliable Dividend Stocks With Yields Above 5% You Can Buy With $100 in July
BMY

Motley Fool

21 days ago

3 Reliable Dividend Stocks With Yields Above 5% You Can Buy With $100 in July

Eisai and Bristol Myers Squibb terminate ADC development deal
BMY

Pharmaceutical Technology

25 days ago

Eisai and Bristol Myers Squibb terminate ADC development deal

BMY

MT Newswires

25 days ago

Bristol-Myers Squibb to Pay $2.7 Million to Settle Potential Anti-Competition Case, Israeli Agency Says

Bristol Myers to pay $2.7 million to settle Israel anti-competition charges
BMY

Reuters

a month ago

Bristol Myers to pay $2.7 million to settle Israel anti-competition charges

Eisai and Bristol Myers cancel cancer ADC deal
BMY

BioPharma Dive

a month ago

Eisai and Bristol Myers cancel cancer ADC deal

Is Bristol Myers Squibb Stock a Buy?
BMY

Motley Fool

a month ago

Is Bristol Myers Squibb Stock a Buy?

Novo Nordisk Buys 2seventy's Hemophilia A Program, Divestiture Supports Exclusive Focus On Abecma
BMY

Benzinga

a month ago

Novo Nordisk Buys 2seventy's Hemophilia A Program, Divestiture Supports Exclusive Focus On Abecma

Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know
BMY

Zacks

a month ago

Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know

Bristol Myers Squibb (BMY) Stock Declines While Market Improves: Some Information for Investors
BMY

Zacks

a month ago

Bristol Myers Squibb (BMY) Stock Declines While Market Improves: Some Information for Investors

BMS expands Krazati’s FDA label to include colorectal cancer
BMY

Clinical Trials Arena

a month ago

BMS expands Krazati’s FDA label to include colorectal cancer

Bristol Myers' (BMY) Krazati Gets FDA Nod for Colorectal Cancer
BMY

Zacks

a month ago

Bristol Myers' (BMY) Krazati Gets FDA Nod for Colorectal Cancer

BMS expands Krazati’s FDA label to include colorectal cancer
BMY

Pharmaceutical Technology

a month ago

BMS expands Krazati’s FDA label to include colorectal cancer

FDA Approves Bristol Myers Squibb's Combination Therapy For Colorectal Cancer Patients With Certain Type Of Gene Mutation
BMY

Benzinga

a month ago

FDA Approves Bristol Myers Squibb's Combination Therapy For Colorectal Cancer Patients With Certain Type Of Gene Mutation

3 No-Brainer Stocks to Buy for Under $100 Right Now
BMY

Motley Fool

a month ago

3 No-Brainer Stocks to Buy for Under $100 Right Now

3 High-Yield Dividend Stocks Near Their 52-Week Lows to Buy and Hold
BMY

Motley Fool

a month ago

3 High-Yield Dividend Stocks Near Their 52-Week Lows to Buy and Hold

Bristol Myers Squibb Announces U.S. FDA Accelerated Approval of KRAZATI® (adagrasib) in Combination with Cetuximab for Adult Patients with Previously Treated KRAS G12C-Mutated Locally Advanced or Metastatic Colorectal Cancer (CRC)
BMY

Business Wire

a month ago

Bristol Myers Squibb Announces U.S. FDA Accelerated Approval of KRAZATI® (adagrasib) in Combination with Cetuximab for Adult Patients with Previously Treated KRAS G12C-Mutated Locally Advanced or Metastatic Colorectal Cancer (CRC)

BMY

MT Newswires

a month ago

Bristol-Myers Squibb's Colorectal Cancer Therapy Receives FDA Approval

BMY

MT Newswires

a month ago

Bristol-Myers Squibb Says EMA Validates Application for Subcutaneous Opdivo

European Medicines Agency Validates Bristol Myers Squibb’s Application for Subcutaneous Nivolumab
BMY

Business Wire

a month ago

European Medicines Agency Validates Bristol Myers Squibb’s Application for Subcutaneous Nivolumab

Bristol Myers Squibb to Report Results for Second Quarter 2024 on July 26, 2024
BMY

Business Wire

a month ago

Bristol Myers Squibb to Report Results for Second Quarter 2024 on July 26, 2024

Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know
BMY

Zacks

a month ago

Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know

Bristol Myers Squibb Elects Michael R. McMullen to Board of Directors
BMY

Business Wire

a month ago

Bristol Myers Squibb Elects Michael R. McMullen to Board of Directors

Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb
BMY

Motley Fool

a month ago

Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb

Bristol Myers Squibb Announces Dividend
BMY

Business Wire

a month ago

Bristol Myers Squibb Announces Dividend

FDA grants approval for Bristol Myers Squibb’s Augtyro for solid tumours
BMY

Pharmaceutical Technology

a month ago

FDA grants approval for Bristol Myers Squibb’s Augtyro for solid tumours

3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade
BMY

Motley Fool

a month ago

3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade

BMY

Morningstar Research

a month ago

Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover

Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Augtyro
BMY

Zacks

a month ago

Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Augtyro

BMY

MT Newswires

a month ago

Bristol-Myers Squibb's Augtyro Gets FDA Accelerated Approval for Treatment of Solid Tumors

U.S. Food and Drug Administration Approves Augtyro™ (repotrectinib), a Next-Generation Tyrosine Kinase Inhibitor (TKI), for the Treatment of Patients with NTRK-Positive Locally Advanced or Metastatic Solid Tumors
BMY

Business Wire

a month ago

U.S. Food and Drug Administration Approves Augtyro™ (repotrectinib), a Next-Generation Tyrosine Kinase Inhibitor (TKI), for the Treatment of Patients with NTRK-Positive Locally Advanced or Metastatic Solid Tumors

Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know
BMY

Zacks

a month ago

Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know

BMY

MT Newswires

a month ago

Evotec Gets $20 Million Milestone Payment in Neurodegenerative Disease Collaboration With Bristol Myers Squibb

Bristol Myers Squibb (BMY) Beats Stock Market Upswing: What Investors Need to Know
BMY

Zacks

a month ago

Bristol Myers Squibb (BMY) Beats Stock Market Upswing: What Investors Need to Know

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia
BMY

Business Insider

2 months ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women
BMY

Insider Monkey

2 months ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase
BMY

Reuters

2 months ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

BMY

Insider Monkey

2 months ago

Best Date Night Fragrance in 2024

France's Macron calls snap legislative elections after EU poll blow
BMY

AFP

2 months ago

France's Macron calls snap legislative elections after EU poll blow

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events
BMY

Investor's Business Daily

2 months ago

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events

Toronto Pearson conducts annual full-scale emergency exercise
BMY

CNW Group

2 months ago

Toronto Pearson conducts annual full-scale emergency exercise

European Union Vote Delivers Shift to Right, in Blow to French and German Governments
BMY

The Wall Street Journal

2 months ago

European Union Vote Delivers Shift to Right, in Blow to French and German Governments

Bristol-Myers Squibb Insiders Sold US$1.1m Of Shares Suggesting Hesitancy
BMY

Simply Wall St.

2 months ago

Bristol-Myers Squibb Insiders Sold US$1.1m Of Shares Suggesting Hesitancy

FDA Approves Geron's First Commercial Drug, Competes With Bristol Myers Squibb's Blood Cancer Drug
BMY

Benzinga

2 months ago

FDA Approves Geron's First Commercial Drug, Competes With Bristol Myers Squibb's Blood Cancer Drug

BMY

Argus Research

2 months ago

Analyst Report: Bristol-Myers Squibb Co.

BMY

Argus Research

2 months ago

Market Update: BMY, CMI, HUM, BBWI, LULU

I-Mab and BMS assess givastomig for gastric and oesophageal cancer
BMY

Pharmaceutical Technology

2 months ago

I-Mab and BMS assess givastomig for gastric and oesophageal cancer

Here’s Why Jim Cramer Says You Should Not Buy Bristol-Myers Squibb Co (NYSE:BMY)
BMY

Insider Monkey

2 months ago

Here’s Why Jim Cramer Says You Should Not Buy Bristol-Myers Squibb Co (NYSE:BMY)

BMY

MT Newswires

2 months ago

I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers

BMS’ Opdivo-Yervoy treatment improves survival in hepatocellular carcinoma trial
BMY

Clinical Trials Arena

2 months ago

BMS’ Opdivo-Yervoy treatment improves survival in hepatocellular carcinoma trial

Bristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo (Revised)
BMY

Zacks

2 months ago

Bristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo (Revised)

Share on Social Networks: